The injectable drug delivery market is expected to reach $547.8 billion by 2031 from $326.1 billion in 2022, growing at a CAGR of 12.0% from 2022 to 2031. The market is categorized on the basis of type, therapeutic application, usage pattern, mode of administration, end user, and region. The therapeutic application market is further segmented into autoimmune diseases, hormonal disorders, oncology, orphan diseases, and other therapeutic applications. The oncology segment is expected to witness the highest CAGR in the forecast period.
Factors such as rising incidences of chronic diseases, growth of the biologics market, demand of self-injection devices, and technological advancements, are driving the growth of the injectable drug delivery market. In addition, emphasis on innovation of formulations and improving the delivery of pharmaceuticals is also contributing to the growth of the market. For instance, in November 2012, COMPACT (Collaboration on the Optimization of Macromolecular Pharmaceutical Access to Cellular Targets), a public-private consortium funded by the Innovative Medicines Initiative (IMI), announced the launch of a €30 million ($38.5 million) project, which focuses on improving the delivery of biopharmaceuticals. The consortium would address the major bottlenecks in the development of novel innovative medicines based on biological macromolecules, such as proteins/peptides and oligonucleotides. Such investments are fueling the growth of the market.
Asia is expected to be the fastest-growing country in the injectable drug delivery market. High growth in this market can be attributed to the increased demand for injectable insulin and self-injection devices, particularly pen injectors which are used in the treatment of diabetes.
Request Sample For More Insights : https://www.sdki.us/sample-request-60959
Apart from comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views on key players in the injectable drug delivery market and product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The above-mentioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms to garner a greater market share. Firms purchasing the report can use one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
Access Free PDF With Graphs and Charts : https://www.sdki.us/sample-request-60959
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios of the top players in the injectable drug delivery market. The report analyzes this market by type, therapeutic application, usage pattern, mode of administration, end user, and region
• Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the injectable drug delivery market
Injectable Drug Delivery Market
Primary Cells Market
Healthcare Asset Management Market
Medical Exoskeleton Market
Veterinary Chemistry Analyzer Market
Cell Counting Market
Bowel Management Systems Market
Blockchain Technology in Healthcare Market
Oxygen Therapy Equipment Market